Sichuan Qiaoyuan Gas (301286.SZ) intends to launch a restricted stock incentive plan with a limit of no more than 741,600 shares.
Qiaoyuan Group (301286.SZ) disclosed the 2025 Restricted Stock Incentive Plan (draft), the company's incentive...
Sichuan Qiaoyuan Gas (301286.SZ) disclosed the 2025 Restricted Stock Incentive Plan (draft), in which the company plans to grant a total of no more than 741,600 shares of equity to incentive objects, accounting for approximately 0.185% of the total share capital at the time of the announcement of the draft plan. No reserved equity is set aside. The first type of restricted stock to be granted is 66,000 shares, and the second type is 675,600 shares. The grant price for the first type of restricted stock is 17.64 yuan per share, and for the second type, it is also 17.64 yuan per share.
The incentive objects under this incentive plan will not exceed 231 individuals, including directors, senior management, middle management, and core employees who were serving in the company (including consolidated statements and subsidiaries) at the time of the announcement of the incentive plan. The effective period for the first type of restricted stock extends from the registration of the restricted stock to the end of the restriction on sale or repurchase, up to a maximum of 48 months; for the second type, it extends from the grant of the restricted stock to the end of ownership or expiration, up to a maximum of 36 months.
Related Articles

GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.
GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.

RECOMMEND

Trump Signals End to Trade Talks, Vows to Impose Tariffs Unilaterally Ahead of July 9 Deadline
30/06/2025

One License Unlocks HKD 23.4 Billion Surge: Unpacking Hong Kong’s Ambitions as a Global Virtual Asset Hub
30/06/2025

16 Companies Submit IPO Applications in One Day; Hong Kong IPO Fundraising Hits Three-Year High
30/06/2025